Arthur M. Cohen & Associates LLC Raises Position in Colgate-Palmolive (NYSE:CL)

Arthur M. Cohen & Associates LLC increased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 8.2% during the 4th quarter, Holdings Channel reports. The institutional investor owned 2,650 shares of the company’s stock after purchasing an additional 200 shares during the period. Arthur M. Cohen & Associates LLC’s holdings in Colgate-Palmolive were worth $241,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in CL. FMR LLC lifted its stake in shares of Colgate-Palmolive by 65.6% during the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after buying an additional 2,674,807 shares during the period. Barclays PLC raised its stake in Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after acquiring an additional 2,132,747 shares during the last quarter. State Street Corp lifted its position in Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after acquiring an additional 1,784,411 shares during the period. Nordea Investment Management AB grew its stake in Colgate-Palmolive by 32.5% during the 4th quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock valued at $462,121,000 after purchasing an additional 1,247,731 shares during the last quarter. Finally, AQR Capital Management LLC increased its holdings in shares of Colgate-Palmolive by 58.6% in the second quarter. AQR Capital Management LLC now owns 2,416,943 shares of the company’s stock valued at $234,540,000 after purchasing an additional 892,706 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on CL shares. Barclays decreased their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. JPMorgan Chase & Co. reduced their target price on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday. UBS Group lowered their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday. Finally, Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $101.11.

Colgate-Palmolive Stock Up 0.3 %

Shares of NYSE CL opened at $88.79 on Friday. The firm has a market cap of $72.55 billion, a price-to-earnings ratio of 25.44, a price-to-earnings-growth ratio of 3.01 and a beta of 0.44. The company’s 50-day simple moving average is $92.27 and its 200-day simple moving average is $97.78. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 52-week low of $79.69 and a 52-week high of $109.30.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.25%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.37% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.